Xanthan-gum-containing pharmaceutical preparation for joint intracavity injection

Abstract

The invention provides a xanthan-gum-containing pharmaceutical preparation for joint intracavity injection, which is characterized by containing xanthan gum. In the preparation, xanthan gum used as a pharmaceutical component for joint cavity injection has the advantages of favorable viscoelasticity and favorable lubricating property, has particular thixotropy, can be used as an excellent pharmaceutical release-control carrier, and can act in the joint cavity for a long time. The pharmaceutical preparation can improve and treat rheumatism, rheumatoid arthritis, osteoarthritis, synovitis and / orcartilage injury, and effectively relieve pain of patients.

Description

Technical field [0001] The invention belongs to the technical field of medicine and provides a pharmaceutical preparation for intra-articular injection containing xanthan gum. Background technique [0002] Osteoarthritis, also known as osteoarthritis, degenerative arthritis, proliferative arthritis, senile arthritis and hypertrophic arthritis, etc., occur in the knee joints, hip joints, spine and In finger joints and other parts, the articular cartilage has undergone degeneration, and bone spurs are formed on the edges of the joints. Osteoarthritis is more common in the elderly. As the average life span of human beings increases, the incidence of osteoarthritis is getting higher and higher. It seriously hinders work and becomes one of the most common reasons for the loss of labor after the age of 50. As a result, bones and joints Inflammation has become a major problem to be solved urgently. [0003] The pathogenesis of osteoarthritis is not well understood. Its occurrence and d...

AI Technical Summary

Problems solved by technology

However, although sodium hyaluronate alone can repair the damaged cartilage and treat osteoarthritis fundamentally, the repair speed is slow and the required course of treatment is long.

Images